𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1

✍ Scribed by Sonja A. Rasmussen; Jennifer Overman; Susanne A.M. Thomson; Steven D. Colman; Corinne R. Abernathy; Rachael E. Trimpert; Rebecca Moose; Gurinder Virdi; Kyle Roux; Mislen Bauer; Amyn M. Rojiani; Bernard L. Maria; David Muir; Margaret R. Wallace


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
158 KB
Volume
28
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Malignant and benign tumors in patients
✍ Madeleine E.Β T. ZΓΆller; Birgitta Rembeck; Anders OdΓ©n; Matilda Samuelsson; Lenna πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 90 KB

## Background: The development of malignant and benign tumors in patient with neurofibromatosis type 1 (nf1) was investigated in a long term follow-up study of 70 adult nf1 patients living in gΓΆteborg, sweden, on january 1, 1978. their mean age at that time was 44 years (range, 20-81 years). the 70

BRCA1 gene mutation and loss of heterozy
✍ Toyoaki Uchida; Chunxi Wang; Takefumi Sato; Jiangping Gao; Rikiya Takashima; Aki πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 113 KB πŸ‘ 1 views

The tumor suppressor gene BRCA1 on chromosome 17q21 has been characterized and shown to be mutated in patients with familial breast and ovarian cancer. Several studies examined the relatives of women with breast cancer and noted an association with ovarian and prostate cancer. This study investigate

Consistent allelic loss on mouse chromos
✍ Bo Yuan; Ling Hong Hu; Eric M. Lentsch; Alice Shum-Siu; Fred J. Hendler πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 306 KB πŸ‘ 2 views

We have previously shown that all CBA/J mice exposed to 4-nitroquinoline-1-oxide (4NQO) eventually develop oral cavity squamous cell carcinomas, and two-thirds of these tumors have Ha-ras-1 (Hras1) point mutations at codon 12. Half of the tumors with Hras1 mutations have loss of heterozygosity (LOH)